0.1482
price down icon3.39%   -0.0052
 
loading
Schlusskurs vom Vortag:
$0.1534
Offen:
$0.142
24-Stunden-Volumen:
49.21M
Relative Volume:
22.65
Marktkapitalisierung:
$13.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.88M
KGV:
-0.1976
EPS:
-0.75
Netto-Cashflow:
$-25.20M
1W Leistung:
+2.28%
1M Leistung:
-13.84%
6M Leistung:
-51.36%
1J Leistung:
-85.61%
1-Tages-Spanne:
Value
$0.1285
$0.1521
1-Wochen-Bereich:
Value
$0.1285
$0.187
52-Wochen-Spanne:
Value
$0.112
$1.74

In 8 Bio Inc Stock (INAB) Company Profile

Name
Firmenname
In 8 Bio Inc
Name
Telefon
(646) 600-6438
Name
Adresse
EMPIRE STATE BUILDING, NEW YORK
Name
Mitarbeiter
18
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
INAB's Discussions on Twitter

Vergleichen Sie INAB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
INAB
In 8 Bio Inc
0.1482 13.15M 0 -31.88M -25.20M -0.75
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

In 8 Bio Inc Stock (INAB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-03-18 Eingeleitet Laidlaw Buy
2022-08-30 Eingeleitet H.C. Wainwright Buy

In 8 Bio Inc Aktie (INAB) Neueste Nachrichten

pulisher
May 29, 2025

Fierce Biotech Layoff Tracker 2025: Keros cuts 70 jobs; iTeos winds down - Fierce Biotech

May 29, 2025
pulisher
May 28, 2025

Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $20.33 - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Global Immunoprecipitation Market Set to Grow at a CAGR of 6-8%: Key Drivers and Challenges by 2029 - PharmiWeb.com

May 27, 2025
pulisher
May 26, 2025

DNA Polymerase Market to Grow at 6–8% CAGR Driven by Genomics, PCR, and CRISPR Technologies by 2029 - PharmiWeb.com

May 26, 2025
pulisher
May 22, 2025

Layoff Tracker: Boundless Laying Off 33% of Staff - BioSpace

May 22, 2025
pulisher
May 20, 2025

Caisse Française de Financement Local: EMTN 2025-8 SOCIAL - The Manila Times

May 20, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Sells 592,968 Shares of bluebird bio, Inc. (NASDAQ:BLUE) - Defense World

May 18, 2025
pulisher
May 14, 2025

KALA BIO: Q1 Earnings Snapshot - The Washington Post

May 14, 2025
pulisher
May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Takes Position in 8×8, Inc. (NASDAQ:EGHT) - Defense World

May 14, 2025
pulisher
May 13, 2025

Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - MSN

May 13, 2025
pulisher
May 13, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - GlobeNewswire

May 12, 2025
pulisher
May 11, 2025

TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 09, 2025

8 Best Medical Simulators On Steam, Ranked - Game Rant

May 09, 2025
pulisher
May 09, 2025

Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential - Yahoo Finance

May 09, 2025
pulisher
May 08, 2025

bluebird bio, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your RightsBLUE - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Shareholders that lost money on bluebird bio, Inc. (BLUE) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

TELA Bio Reports First Quarter 2025 Financial Results - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire Inc.

May 07, 2025
pulisher
May 07, 2025

TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”) - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

TELA Bio Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 06, 2025

Instil Bio Inc expected to post a loss of $2.59 a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 06, 2025

Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases - GlobeNewswire

May 06, 2025
pulisher
May 05, 2025

INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th - The Manila Times

May 05, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
May 01, 2025

Nuvation Bio CFO to Share Latest Oncology Strategy at Exclusive Citizens Conference Next Week - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and - GlobeNewswire

May 01, 2025
pulisher
Apr 30, 2025

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - BioSpace

Apr 30, 2025
pulisher
Apr 29, 2025

Annovis Bio Appoints Hui Liu as Director of Biostatistics - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting - Yahoo Finance

Apr 29, 2025
pulisher
Apr 27, 2025

Cerity Partners LLC Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Tevogen Bio Announces 2025 Annual Meeting - GlobeNewswire

Apr 25, 2025
pulisher
Apr 20, 2025

TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN

Apr 20, 2025
pulisher
Apr 18, 2025

TELA Bio to Announce First Quarter 2025 Financial Results - The Manila Times

Apr 18, 2025
pulisher
Apr 17, 2025

Tevogen Bio Signs Agreement with CD 8 Technology - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Medical Tech Leader TELA Bio Schedules Q1 2025 Earnings: Key Growth Updates Expected - Stock Titan

Apr 17, 2025
pulisher
Apr 16, 2025

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1? - Insider Monkey

Apr 16, 2025
pulisher
Apr 16, 2025

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

Vyant Bio (OTCMKTS:VYNT) Trading 7.8% Higher – Time to Buy? - Defense World

Apr 15, 2025
pulisher
Apr 10, 2025

Amtech Systems, Tesla And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Apr 10, 2025
pulisher
Apr 09, 2025

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108 - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)April 8, 2025 - BioSpace

Apr 09, 2025
pulisher
Apr 08, 2025

South Korean firms ABL Bio, Yuhan advance bispecific antibodies in cancer treatment - Chosunbiz

Apr 08, 2025

Finanzdaten der In 8 Bio Inc-Aktie (INAB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):